Standard BioTool creates, manufactures, and markets a range of products and services, including instruments, consumables, reagents and software that are used by researchers and clinical labs worldwide. Co. markets technologies and life science tools, including preparatory and analytical instruments for Mass Cytometry, polymerase chain reaction, Library Preparation, Single Cell Genomics, and consumables, including integrated fluidic circuits, assays, and reagents. Co.'s product offerings include: Mass Cytometry, Microfluidics and Single Cell Microfluidics. We show 8 historical shares outstanding datapoints in our LAB shares outstanding history coverage, used to compute LAB market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing LAB market cap history over the course of time is important for investors
interested in comparing LAB's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of LAB versus a peer is one thing; comparing
LAB market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like LAB can fluctuate over the course of history.
With this page we aim to empower investors researching LAB by allowing them to research the LAB market cap history. |
Free LAB Email Alerts:
Video: The Importance of Market Cap
